CAPTRUST Financial Advisors
GMAB icon

CAPTRUST Financial Advisors’s Genmab GMAB Stock Holding History

CAPTRUST Financial Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$711K Buy
25,873
+358
+1% +$9.51K ﹤0.01% 1943
2026
Q1 		$685K Sell
25,515
-24,920
-49% -$747K ﹤0.01% 1823
2025
Q4 		$1.55M Buy
50,435
+22,053
+78% +$687K ﹤0.01% 1223
2025
Q3 		$870K Buy
28,382
+5,940
+26% +$145K ﹤0.01% 1510
2025
Q2 		$464K Buy
22,442
+526
+2% +$10.8K ﹤0.01% 1778
2025
Q1 		$429K Sell
21,916
-8,296
-27% -$174K ﹤0.01% 1727
2024
Q4 		$631K Sell
30,212
-2,611
-8% -$57.4K ﹤0.01% 1487
2024
Q3 		$800K Sell
32,823
-12,027
-27% -$322K ﹤0.01% 1320
2024
Q2 		$1.13M Sell
44,850
-1,453
-3% -$41.2K ﹤0.01% 1072
2024
Q1 		$1.38M Buy
46,303
+6,963
+18% +$205K 0.01% 961
2023
Q4 		$1.25M Sell
39,340
-5,025
-11% -$158K ﹤0.01% 1142
2023
Q3 		$1.56M Buy
44,365
+38,797
+697% +$1.48M 0.01% 961
2023
Q2 		$212K Sell
5,568
-520
-9% -$20.7K ﹤0.01% 2220
2023
Q1 		$230K Sell
6,088
-1,303
-18% -$50.1K ﹤0.01% 1960
2022
Q4 		$313K Buy
+7,391
New +$305K ﹤0.01% 1618
2022
Q3 		– Sell
-2,442
Closed -$79K – 2863
2022
Q2 		$79K Sell
2,442
-216
-8% -$7K ﹤0.01% 2387
2022
Q1 		$96K Buy
2,658
+1,017
+62% +$34.9K ﹤0.01% 2302
2021
Q4 		$65K Buy
1,641
+227
+16% +$9.47K ﹤0.01% 2465
2021
Q3 		$62K Buy
1,414
+266
+23% +$11.9K ﹤0.01% 2440
2021
Q2 		$47K Buy
1,148
+90
+9% +$3.47K ﹤0.01% 2548
2021
Q1 		$35K Buy
1,058
+658
+165% +$24.7K ﹤0.01% 2658
2020
Q4 		$16K Hold
400
– – ﹤0.01% 2356
2020
Q3 		$15K Buy
+400
New +$14.5K ﹤0.01% 2105

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CAPTRUST Financial Advisors's GMAB Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Genmab (GMAB) stake by 1.4% in Q2 2026, buying an estimated $9.51K and bringing the position to 25,873 shares worth $711K. The position accounts for ﹤0.01% of the portfolio, ranked #1943.

CAPTRUST Financial Advisors first reported a position in GMAB in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.56M in Q3 2023. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • CAPTRUST Financial Advisors held 25,873 shares of Genmab worth $711K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 358 Genmab shares in Q2 2026, an estimated $9.51K.
  • Genmab made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1943 holding.
  • CAPTRUST Financial Advisors first reported a position in Genmab in Q3 2020 and has held it in 23 quarters since.
  • CAPTRUST Financial Advisors's Genmab position peaked at $1.56M in Q3 2023.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.